| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |